Sinopharm's COVID-19 vaccine remained active against S.Africa variant, effect reduced - lab study
- Variants of the virus have stirred concern that they might weaken effects of vaccines and treatments developed prior to their emergence.
Subscribing is the best way to get our best stories immediately.